Vaginal lactobacilli produce anti-inflammatory β-carboline compounds

Area of Science:

• Microbiology
• Immunology
• Pharmacology

Background:

• The vaginal microbiome is typically Lactobacillus-dominant, crucial for immune homeostasis.
• Loss of Lactobacillus dominance correlates with inflammatory conditions like bacterial vaginosis (BV).
• Lactobacillus species, except Lactobacillus iners, are linked to reduced inflammation and pro-inflammatory cytokines.

Purpose of the Study:

• To identify compounds produced by Lactobacillus crispatus with anti-inflammatory properties.
• To investigate the mechanism of action of these compounds on immune signaling pathways.
• To evaluate the therapeutic potential of these compounds in reducing vaginal inflammation.

Main Methods:

• Identification and characterization of β-carboline compounds from Lactobacillus crispatus.
• Assays to determine the effect of compounds on nuclear factor κB (NF-κB) and interferon (IFN) signaling in human cells.
• Assessment of type I interferon receptor (IFNAR) activation in monocytes.
• Topical administration of perlolyrine in a mouse model of genital herpes to assess vaginal inflammation.
• Comparison of compound levels in cervicovaginal lavage (CVL) from healthy individuals and those with BV.

Main Results:

• Lactobacillus crispatus produces anti-inflammatory β-carboline compounds.
• These compounds suppress NF-κB and IFN signaling pathways.
• Perlolyrine significantly reduced vaginal inflammation in a mouse model of genital herpes.
• Compounds are more abundant in CVL from healthy individuals compared to those with BV.

Conclusions:

• Vaginal lactobacilli produce β-carboline compounds that mediate host immune homeostasis.
• These findings highlight a potential therapeutic strategy for managing vaginal inflammation.
• Targeting these compounds could offer novel treatments for BV and related inflammatory conditions.